Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population

View ORCID ProfileShaza B. Zaghlool, View ORCID ProfileAnna Halama, Nisha Stephan, Manonanthini Thangam, Emma Ahlqvist, Omar M. E. Albagha, Abdul Badi Abou⍰Samra, View ORCID ProfileKarsten Suhre
doi: https://doi.org/10.1101/2022.01.13.22269204
Shaza B. Zaghlool
1Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shaza B. Zaghlool
Anna Halama
1Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anna Halama
Nisha Stephan
1Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manonanthini Thangam
2Department of Clinical Sciences Malmö, Lund University, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma Ahlqvist
2Department of Clinical Sciences Malmö, Lund University, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Omar M. E. Albagha
3College of Health and Life Sciences, Hamad Bin Khalifa University, Education City, Doha, Qatar
4Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdul Badi Abou⍰Samra
5Qatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karsten Suhre
1Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Karsten Suhre
  • For correspondence: kas2049@qatar-med.cornell.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Type 2 diabetes (T2D) has a heterogeneous etiology which is increasingly recognized to influence the risk of complications and choice of treatment. A data driven cluster analysis in four separate European populations of patients with type 2 diabetes identified four subtypes of severe insulin dependent (SIDD), severe insulin resistant (SIRD), mild obesity-related (MOD), and mild age-related (MARD) (Ahlqvist et al., Lancet Diabetes Endocrinology, 2018). Our aim was to extend this classification to the Arab population of Qatar and characterize the biological processes that differentiate these subtypes in relation to metabolomic and proteomic signatures.

Methods The Ahlqvist et al. subtype clustering approach was applied to 631 individuals with T2D from the Qatar Biobank (QBB) and validated in an independent set of 420 participants from the same population. The association between blood metabolites (n=1,159) and protein levels (n=1,305) with each cluster were established.

Findings The four subtypes of T2D were reproduced and validated in the population of Qatar. Cluster-specific metabolomic and proteomic associations revealed subtype-specific molecular processes. Activation of the complement system with many features of autoimmune diabetes and reduced 1,5-anhydroglucitol (1,5-AG) characterized SIDD, with evidence of impaired insulin signaling in SIRD, elevated leptin and fatty acid binding protein in MOD, whilst MARD appeared to be the healthiest subgroup.

Interpretation We have replicated the four T2D clusters in an Arab population and identified distinct metabolic and proteomic signatures, providing insights into underlying etiology with the potential to deploy subtype-specific treatment options.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study is supported by the Biomedical Research Program at Weill Cornell Medicine in Qatar, a program funded by the Qatar Foundation, and by QNRF grant NPRP11C-0115-180010. Qatar Biobank is supported by Qatar Foundation. The statements made herein are solely the responsibility of the authors. EA was funded by grants from the Swedish Research Council (2020-02191) and the Novo Nordisk foundation (NNF18OC0034408). Olink measurements in ANDIS were sponsored by Olink Proteomics (Uppsala, Sweden).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All QBB participants signed an informed consent form prior to their participation. The study was approved by HMC ethics committee and the QBB institutional review board. Use of the Qatar Biobank data was approved by the QBB IRB under reference Ex -2019-RES-ACC-0160-0083. All study participants provided written informed consent.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The informed consent given by the study participants does not cover posting of participant level phenotype data in public databases. However, data are available upon request from Qatar Biobank (QBB) (https://www.qatarbiobank.org.qa/research/how-to-apply). Requests are submitted online and are subject to approval by the QBB board.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 13, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population
Shaza B. Zaghlool, Anna Halama, Nisha Stephan, Manonanthini Thangam, Emma Ahlqvist, Omar M. E. Albagha, Abdul Badi Abou⍰Samra, Karsten Suhre
medRxiv 2022.01.13.22269204; doi: https://doi.org/10.1101/2022.01.13.22269204
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population
Shaza B. Zaghlool, Anna Halama, Nisha Stephan, Manonanthini Thangam, Emma Ahlqvist, Omar M. E. Albagha, Abdul Badi Abou⍰Samra, Karsten Suhre
medRxiv 2022.01.13.22269204; doi: https://doi.org/10.1101/2022.01.13.22269204

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Endocrinology (including Diabetes Mellitus and Metabolic Disease)
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8783)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1861)
  • Geriatric Medicine (178)
  • Health Economics (388)
  • Health Informatics (1291)
  • Health Policy (644)
  • Health Systems and Quality Improvement (491)
  • Hematology (207)
  • HIV/AIDS (394)
  • Infectious Diseases (except HIV/AIDS) (10557)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1754)
  • Nursing (103)
  • Nutrition (266)
  • Obstetrics and Gynecology (342)
  • Occupational and Environmental Health (461)
  • Oncology (964)
  • Ophthalmology (282)
  • Orthopedics (107)
  • Otolaryngology (176)
  • Pain Medicine (117)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (264)
  • Primary Care Research (219)
  • Psychiatry and Clinical Psychology (1843)
  • Public and Global Health (3983)
  • Radiology and Imaging (654)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (535)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)